Completed PHASE4 INTERVENTIONAL 2-arm NCT06648265

EFFECTS OF TRANEXAMIC ACID IN TUMESCENT SOLUTION FOR LIPOSUCTION PROCEDURES (ARMTXA)

IMPACT OF TRANEXAMIC ACID IN TUMESCENT SOLUTION ON POSTOPERATIVE OUTCOMES AFTER LIPOSUCTION: A DOUBLE-BLIND, CONTRALATERAL ARM RANDOMIZED CLINICAL TRIAL

Sponsor: Total Definer Research Group

Conditions Bruising Ecchymosis Edema Arm Hematoma Inflammation Liposuction Skin Condition

Interventions Tranexamic Acid (Topical) Tumescent solution with dilute lidocaine and epinephrine

Updated 3 times since 2024 Last updated: Apr 27, 2025 Started: Jan 20, 2022 Primary completion: Feb 15, 2024 Completion: Jun 13, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Bruising and Ecchymosis, this trial is completed. The trial is conducted by Total Definer Research Group and has accumulated 3 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

3 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
May 2025 — Sep 2025 [monthly]

Completed PHASE4
Nov 2024 — May 2025 [monthly]

Completed PHASE4

First recorded

Jan 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Total Definer Research Group

Data source: Total Definer Research Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bogotá, Colombia